Response to: Correspondence on 'Clinical value of pre-operative scoring systems to predict leiomyosarcoma: results of a validation study in 177 patients from the NOGGO-REGSA Registry' by Vollmer et al

Affiliations

¹ Gynecology and Gynecologic Oncology, University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany mateja.condic@ukbonn.de.
² Department of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany.
³ Gynecology and Gynecologic Oncology, University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany.

Free article

Comment

Mateja Condic et al. Int J Gynecol Cancer. 2022.

Free article

. 2022 Jul 4;32(7):964.

doi: 10.1136/ijgc-2022-003662.

¹ Gynecology and Gynecologic Oncology, University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany mateja.condic@ukbonn.de.
² Department of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany.
³ Gynecology and Gynecologic Oncology, University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany.

No abstract available

Keywords: Sarcoma.

Conflict of interest statement

Competing interests: None declared.

Clinical value of pre-operative scoring systems to predict leiomyosarcoma: results of a validation study in 177 patients from the NOGGO-REGSA Registry.
Condic M, Egger EK, Hohenberger P, Staerk C, Mayr A, Armbrust R, Roser E, Mustea A, Sehouli J. Condic M, et al. Int J Gynecol Cancer. 2022 May 3;32(5):619-625. doi: 10.1136/ijgc-2021-003334. Int J Gynecol Cancer. 2022. PMID: 35288460
Correspondence on 'Clinical value of pre-operative scoring systems to predict leiomyosarcoma: results of a validation study in 177 patients from the NOGGO-REGSA Registry' by Condic et al.
Vollmer M, Köhler G. Vollmer M, et al. Int J Gynecol Cancer. 2022 Jul 4;32(7):963. doi: 10.1136/ijgc-2022-003607. Int J Gynecol Cancer. 2022. PMID: 35618309 No abstract available.